Intestinal perforation associated with octreotide therapy in scleroderma.
Malcolm
A
A
Ellard
K
K
D000368:Aged; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D007416:Intestinal Perforation / Q000139:chemically induced*; D015282:Octreotide / Q000009:adverse effects*; D012595:Scleroderma, Systemic / Q000188:drug therapy*
D005765:Gastrointestinal Agents; D015282:Octreotide